methylthioinosine has been researched along with Congenital Zika Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordeiro, MT; de Araújo, CMCS; de Carvalho, OV; de Mendonça, LR; de Oliveira Franca, RF; Félix, DM; Pena, LJ; Silva Júnior, A | 1 |
| de Boer, NKH; Meijer, B | 1 |
2 other study(ies) available for methylthioinosine and Congenital Zika Syndrome
| Article | Year |
|---|---|
The thiopurine nucleoside analogue 6-methylmercaptopurine riboside (6MMPr) effectively blocks Zika virus replication.
Topics: Animals; Antiviral Agents; Brazil; Cell Line; Cell Survival; Epithelial Cells; Humans; Methylthioinosine; Neurons; Virus Replication; Zika Virus; Zika Virus Infection | 2017 |
Accelerating with the brakes on?
Topics: Humans; Methylthioinosine; Nucleosides; Virus Replication; Zika Virus; Zika Virus Infection | 2017 |